Francais | English | Espanõl

Schering-Plough

From Wikipedia, the free encyclopedia

Jump to: navigation, search
Schering-Plough Corporation

<tr><td colspan="2" style="text-align:center; padding:16px 0 16px 0;">Image:Schering-Plough logo.png</td></tr>

Type Public (NYSE: SGP)
Founded 1971 (by merger with Plough, Inc.)
Headquarters Kenilworth, New Jersey

<tr><th style="text-align:right; padding-right:0.75em;">Key people</th><td>Fred Hassan, (CEO, Chairman of the Board)</td></tr><tr><th style="text-align:right; padding-right:0.75em;">Industry</th><td>Pharmaceuticals</td></tr><tr><th style="text-align:right; padding-right:0.75em;">Products</th><td>Remicade
Levitra
</td></tr><tr><th style="text-align:right; padding-right:0.75em;">Revenue</th><td>$9.5 billion USD (2005)</td></tr><tr><th style="text-align:right; padding-right:0.75em;">Employees</th><td>32,000</td></tr><tr><th style="text-align:right; padding-right:0.75em;">Website</th><td>http://www.schering-plough.com/</td></tr>

Schering-Plough Corporation (NYSE: SGP) is a pharmaceutical company which traces its history back to 1851 when Ernst Schering founded Schering AG in Germany. Following the entry of the United States into World War II in 1941, U.S. President Franklin Delano Roosevelt ordered Schering AG's U.S. assets be seized. These became Schering Corporation. The company was placed under a government administratorship until 1952, when it was released and its assets sold to the private sector. In 1971, the Schering Corporation merged with Plough to form Schering Plough.

Today Schering Plough manufactures several pharmaceutical drugs, the most well-known of which are the allergy drugs Claritin and Clarinex, and through a collaboration with Merck & Co., Zetia, an anti-cholesterol drug.

Schering Plough also owns and operates the major foot care brand name Dr. Scholl's and the skin care line Coppertone.

As of June 2005, Schering Plough has 1.4% market share in the U.S., placing it at #17 in the top 20 pharmaceutical corporations by sales compiled by IMS Health.

One of their plants, in Upper Hutt, New Zealand is the largest single site for the production of veterinary vaccines in the world. This is largely due to the fact that New Zealand's isolation has formed a natural quarantine and is free of rabies, foot and mouth, scrapie, bovine spongiform encephalopathy and many other livestock diseases. It formerly had echinococcosis, but this has been eradicated. The site is known locally as "Coopers Animal Health," a trademark still in use by Schering Plough in Australia, but not elsewhere.

In 2000, Schering Plough bought a new campus in Summit, New Jersey from Novartis. The company plans to make this location its second largest corporate complex in the world after its current $20 million renovation.

Contents

[edit] Products (Medical)

[edit] Prescription products

[edit] Over-the-counter products

[edit] Products (Veterinary)

[edit] Controversy

In 2004, Schering-Plough was accused of violating public trust. [1]

[edit] Diversity

Schering-Plough was named one of the 100 Best Companies for Working Mothers in 2004 and 2005 by Working Mothers magazine.

[edit] References

1. "Doctors Write Prescriptions, Drug Companies Write a Check," Gardiner Harris, NY Times

[edit] External links

Personal tools